BioSpace News Archive

Genetown

New England Biolabs Launches NEBNext Ultra II FS Kit for Robust Enzyme-Based DNA Fragmentation and Library Preparation with as Little as 100 pg of Input DNA

This new kit employs a novel enzymatic fragmentation system that combines fragmentation, end repair and dA-tailing in a single tube, and utilizes a single protocol regardless of input amount or GC content.

November 7, 2017

·

4 min read

Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials

The Imaging Phenomics Company is pleased to announce that James Golando, Chief of Operations at Median Technologies will present on “Optimizing Imaging in Oncology Clinical Trials” during the upcoming Medidata NEXT Global 2017.

November 7, 2017

·

4 min read

Business

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update December 2019

These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the U.S. SEC and is available at www.sec.gov.

November 7, 2017

·

6 min read

BioMidwest

Huber Personalized Medicine Brings GAINSWave to Cincinnati

This breakthrough noninvasive medical procedure uses a form of shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction symptoms.

November 7, 2017

·

2 min read

Business

AlloSource Announces Bob Lay as COO

With over 20 years of experience in both finance and operations, Bob has a broad-based understanding of how each department within an organization impacts another.

November 7, 2017

·

2 min read

Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017

The company intends to host a conference call the same day at 5:00 p.m. ET to discuss the financial results.

November 7, 2017

·

1 min read

Business

Celldex Reports Third Quarter 2017 Results

Cash, cash equivalents and marketable securities as of September 30, 2017 were $140.5 million compared to $154.0 million as of June 30, 2017.

November 7, 2017

·

17 min read

Business

Elite Pharmaceuticals to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017

Stockholder questions should be summited to the company in advance of the call.

November 7, 2017

·

3 min read

Drug Development

Krystal Biotech’s KB103 Granted Orphan Drug Designation by the FDA to Treat Patients With Dystrophic Epidermolysis Bullosa

The drug is currently in preclinical development for dystrophic epidermolysis bullosa, or DEB.

November 7, 2017

·

4 min read

Business

Genovis Signs Distribution Agreement With Shanghai Titan Scientific Ltd.

A growing number of companies in China are focusing on biopharma, at the same time that global pharmaceutical companies are locating their process development and production in the area.

November 7, 2017

·

1 min read